Susanne Behlke
CSO
Med’Inn’Pharma
Besançon, France
13 profile visitsSpeakerGuests
My organisation
MED’INN’Pharma (MIP) is a pre-clinical stage Biotech company founded in 2017 as a spin-off from the French blood bank establishment (EFS) and the French National Institute of Health (INSERM).
Our mission is to use our platform technology to develop a pipeline of disease modifying therapies derived from the secretomes of human cells. We are committed to develop drug candidates with durable efficacy by targeting the root cause of diseases. Our platform derived therapeutics can be tailored to several indications and delivery methods.
RESOLVIX, the lead candidate issued from our technology plateform, is dedicated to actively resolve, heal and regenerate pathologic inflammation in a wide range of degenerative diseases and conditions and with that intended to positively impacting human health span.
About me
My organisation
Med’Inn’Pharma
Speaker sessions (2)
Thursday, 10 October 2024
09:20 - 10:25
Session #1 : Upcoming Innovative Therapies
Location:Petit Kursaal roomTrack:Conference
11:15 - 12:15
Session #1 : Upcoming Innovative Therapies
Location:Petit Kursaal roomTrack:Conference